Clinical Cancer Research, Vol 1, Issue 2 215-222, Copyright © 1995 by American Association for Cancer Research

ARTICLES

Wnt5a cloning, expression, and up-regulation in human primary breast cancers

S Lejeune, EL Huguet, A Hamby, R Poulsom and AL Harris
Imperial Cancer Research Fund, Molecular Oncology Laboratory, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, OX3 9DU, United Kingdom.

Wnt genes are involved in mouse mammary cancer, but their role in human cancer is unknown. Human Wnt5a was cloned from a placental cDNA library and used to assess expression by ribonuclease protection and in situ hybridization in human breast cell lines and in normal, benign, and malignant breast tissues. Human Wnt5a shows over 99% homology at amino acid level with mouse Wnt5a, and 90% with Xenopus Wnt5a. It was expressed only at low levels in breast cell lines and normal breast tissue. Benign proliferations and invasive cancer respectively showed 10-fold and 4-fold higher Wnt5a than normal breast tissues. The greater up-regulation in benign conditions suggests a role in aberrant differentiation. In situ hybridization localized the signal to the epithelial component. Wnt5a is the first member of the Wnt family to demonstrate overexpression in human breast cancer. It was not associated with factors known to affect breast cancer prognosis such as lymph node status or epidermal growth factor receptor status.

This article has been cited by other articles:

				J. Ying, H. Li, J. Yu, K. M. Ng, F. F. Poon, S. C. C. Wong, A. T.C. Chan, J. J.Y. Sung, and Q. Tao WNT5A Exhibits Tumor-Suppressive Activity through Antagonizing the Wnt/ -Catenin Signaling, and Is Frequently Methylated in Colorectal Cancer Clin. Cancer Res., January 1, 2008; 14(1): 55 - 61. [Abstract] [Full Text] [PDF]

				H. Yoshikawa, K. Matsubara, X. Zhou, S. Okamura, T. Kubo, Y. Murase, Y. Shikauchi, M. Esteller, J. G. Herman, X. Wei Wang, et al. WNT10B Functional Dualism: beta-Catenin/Tcf-dependent Growth Promotion or Independent Suppression with Deregulated Expression in Cancer Mol. Biol. Cell, November 1, 2007; 18(11): 4292 - 4303. [Abstract] [Full Text] [PDF]

				S Ripka, A Konig, M Buchholz, M Wagner, B Sipos, G Kloppel, J Downward, T. Gress, and P Michl WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer Carcinogenesis, June 1, 2007; 28(6): 1178 - 1187. [Abstract] [Full Text] [PDF]

				T. N. H. Masckauchan, D. Agalliu, M. Vorontchikhina, A. Ahn, N. L. Parmalee, C.-M. Li, A. Khoo, B. Tycko, A. M.C. Brown, and J. Kitajewski Wnt5a Signaling Induces Proliferation and Survival of Endothelial Cells In Vitro and Expression of MMP-1 and Tie-2 Mol. Biol. Cell, December 1, 2006; 17(12): 5163 - 5172. [Abstract] [Full Text] [PDF]

				K. Leandersson, K. Riesbeck, and T. Andersson Wnt-5a mRNA translation is suppressed by the Elav-like protein HuR in human breast epithelial cells Nucleic Acids Res., September 1, 2006; 34(14): 3988 - 3999. [Abstract] [Full Text] [PDF]

				T. Pukrop, F. Klemm, Th. Hagemann, D. Gradl, M. Schulz, S. Siemes, L. Trumper, and C. Binder Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines PNAS, April 4, 2006; 103(14): 5454 - 5459. [Abstract] [Full Text] [PDF]

				C.-l. Huang, D. Liu, J. Nakano, S. Ishikawa, K. Kontani, H. Yokomise, and M. Ueno Wnt5a Expression Is Associated With the Tumor Proliferation and the Stromal Vascular Endothelial Growth Factor--An Expression in Non-Small-Cell Lung Cancer J. Clin. Oncol., December 1, 2005; 23(34): 8765 - 8773. [Abstract] [Full Text] [PDF]

				D. J. Mulholland, S. Dedhar, G. A. Coetzee, and C. C. Nelson Interaction of Nuclear Receptors with the Wnt/{beta}-Catenin/Tcf Signaling Axis: Wnt You Like to Know? Endocr. Rev., December 1, 2005; 26(7): 898 - 915. [Abstract] [Full Text] [PDF]

				G. Liu, A. Bafico, and S. A. Aaronson The Mechanism of Endogenous Receptor Activation Functionally Distinguishes Prototype Canonical and Noncanonical Wnts Mol. Cell. Biol., May 1, 2005; 25(9): 3475 - 3482. [Abstract] [Full Text] [PDF]

				J. Dejmek, K. Leandersson, J. Manjer, A. Bjartell, S. O. Emdin, W. F. Vogel, G. Landberg, and T. Andersson Expression and Signaling Activity of Wnt-5a/Discoidin Domain Receptor-1 and Syk Plays Distinct but Decisive Roles in Breast Cancer Patient Survival Clin. Cancer Res., January 15, 2005; 11(2): 520 - 528. [Abstract] [Full Text] [PDF]

				J. M. Gonzalez-Sancho, K. R. Brennan, L. A. Castelo-Soccio, and A. M. C. Brown Wnt Proteins Induce Dishevelled Phosphorylation via an LRP5/6- Independent Mechanism, Irrespective of Their Ability To Stabilize {beta}-Catenin Mol. Cell. Biol., June 1, 2004; 24(11): 4757 - 4768. [Abstract] [Full Text] [PDF]

				R. D. Cardiff, A. Rosner, M. A. Hogarth, J. J. Galvez, A. D. Borowsky, and J. P. Gregg Validation: The New Challenge for Pathology Toxicol Pathol, January 1, 2004; 32(1_suppl): 31 - 39. [Abstract] [PDF]

				M. Jonsson, J. Dejmek, P.-O. Bendahl, and T. Andersson Loss of Wnt-5a Protein Is Associated with Early Relapse in Invasive Ductal Breast Carcinomas Cancer Res., January 1, 2002; 62(2): 409 - 416. [Abstract] [Full Text] [PDF]

				W. Tao, D. Pennica, L. Xu, R. F. Kalejta, and A. J. Levine Wrch-1, a novel member of the Rho gene family that is regulated by Wnt-1 Genes & Dev., July 15, 2001; 15(14): 1796 - 1807. [Abstract] [Full Text] [PDF]

				R. C. Humphreys, J. Lydon, B. W. O’Malley, and J. M. Rosen Mammary Gland Development Is Mediated by Both Stromal and Epithelial Progesterone Receptors Mol. Endocrinol., June 1, 1997; 11(6): 801 - 811. [Abstract] [Full Text]

				S.-Y. Lin, W. Xia, J. C. Wang, K. Y. Kwong, B. Spohn, Y. Wen, R. G. Pestell, and M.-C. Hung beta -Catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression PNAS, April 11, 2000; 97(8): 4262 - 4266. [Abstract] [Full Text] [PDF]